| Download a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Taiwan represents a major market for imported, advanced drugs, with per capita
spending on pharmaceuticals among the highest in Asia. This report is ideal
for executives wanting to understand the key drivers in the pharmaceutical
market and have access to a wealth of statistical data, including five-year
market projections. Included with the report are 3 free quarterly updated
outlook reports, enabling you to keep up to date with market developments for
a year.
Includes 3 quarterly updated outlook reports!
Taiwan is a highly developed country, with a standard of living similar to
much of southern Europe. As such, hospital services and staff are of high
quality, although the latter are in short supply. Taiwan has a small domestic
pharmaceutical industry; there are a large number of manufacturers, but they
are almost always at the low end of the technology scale, concentrating on
producing generics, OTC products and Chinese medicines.
Taiwan represents, therefore, a major market for imported, advanced drugs,
with per capita spending on pharmaceuticals among the highest in Asia.
Tawain's economy has been performing well in recent years and imports of
pharmaceuticals have grown steadily in tandem. It is, however, a 'difficult'
market. An opaque regulatory process and often highly discriminatory
reimbursement practices make the market a challenging one in which to sell.
These issues are currently under review although progress is unlikely to be
swift. The burden of national health insurance debts is another area which the
government must address and various cost-cutting measures may be enforced in
the near future.
There is a heavy multinational presence and dominance of generic drugs. Over
70% of the market has been controlled by overseas multinationals since 2001.
Over 100 generic drug manufacturers currently operate in Taiwan.
Provision of healthcare is generally in the private sector. There is
considered to be widespread overuse of services such as outpatient
consultations and drug prescriptions. The government is looking at reducing
this, and interestingly, lowered prices of over 5,000 reimbursable drugs in
late-2006, a move that is unlikely to reduce volume of prescriptions,
especially with reduced patient co-payments, but will instead affect industry
margins, especially that of patented drug manufacturers.
TABLE OF CONTENTS
BACKGROUND DATA
- GEOGRAPHY
- POLITICAL OVERVIEW
- ECONOMIC OVERVIEW
- Economic Indicators 2007-2012
- POPULATION
- Population, 1994-2005
- Population of Major Cities, 2000-2005
- Population Projections
- Projected Population, 2007-2051
- DEMOGRAPHIC INDICATORS
- Principal Demographic Indicators, 1996-2005
- MORTALITY
- Major Causes of Death, 2001-2005
- Cancer Deaths
- Male Cancer Deaths, 2001-04
- Female Cancer Deaths, 2001-04
- MORBIDITY
- Communicable Diseases
- Reported Infectious Diseases, 2001-2005 (Confirmed Cases)
CHARTS
- Map of Taiwan
- Population by Age Group, 2005 (%)
- Projected Population, 2007-2051
HEALTHCARE SYSTEM
- ORGANISATION & ADMINISTRATION
- Medical Care Network
- National Health Insurance Programme
- HEALTH EXPENDITURE
- Total Healthcare Expenditure, 1991-2005
- Health Expenditure by Type, 2005
- Health Expenditure by Type, 1991-2005 (NT$ millions)
- HOSPITAL SERVICES
- Hospitals and Beds, 1997-2005
- Hospitals and Beds by Region, 2005
- Hospitals and Beds by Sector, 2005
- Beds by Specialty, 2005
- Hospitals by Accreditation, 2005
- Hospital Activity
- Daily Average Inpatient Discharges and Operations, 1997-2005
- Daily Average Discharges and Operations by County/City, 2002
- ALOS and Bed Occupancy, 2002
- Nursing Care
- AMBULATORY CARE
- Number of Clinics, 1988-2005
- Clinics by Region, 2005
- Clinics by Type/Owner, 2002
- Daily Average Outpatient Visits, 1995-2005
- MEDICAL PERSONNEL
- Medical Personnel, 2001-05
- Medical Personnel, 2001-2005 (Rate/000 population)
- Physicians
- Number of Physicians, 1988-2005
- Physicians by Region, 2005
- Physicians by Workplace, 2002
- Specialists working in hospitals by ownership and type, 2005
- Dentists
- Number of Dentists, 1988-2005
- Dentists by Region, 2005
ACCESSING THE PHARMACEUTICAL MARKET
- INTRODUCTION
- REGULATORY ENVIRONMENT
- Pharmaceutical Registration/Drug Approval Process
- Free Sales Certificates
- Plant Master File
- Good Manufacturing Practice
- Clinical Trials
- Drug testing
- Surveillance System
- Drug Relief Injuries Fund
- Patent Protection & Intellectual Property Rights
- Pharmaceutical Pricing and Reimbursement
- Over 5,000 drug prices lowered in 2006
- Background
- Patient co-payments
- DISTRIBUTION CHANNELS
- TRADE FAIRS
- DOMESTIC PRODUCTION
- Registered Western Medicine Manufacturers, 1990-2005
- China Chemical & Pharmaceutical Co Ltd (CCPC)
- China Chemical Synthesis Industrial Co Ltd (CCSI)
- Dah Feng Capsule Industry Co Ltd
- Everlight Chemical Industrial Company
- Formosa Laboratory
- Genovate Biotechnology Co Ltd
- Leily Biotech
- Nan Kuang Pharmaceutical
- Newai Chemical Industry Co Ltd
- ScinoPharm
- Sinphar Pharmaceuticals
- Syn-Tech Chem & Pharm Co Ltd
- Shin Lih Fang Enterprise Co Ltd
- Sintong Chemical Industrial Co
- Taiwan Panbiotic
- Ying Yuan Chemical Pharmaceutical Co Ltd
- Weidar Chemical & Pharmaceutical Co Ltd
- Yung Shim Pharm Ind Co Ltd
- Multinational Activity
- Research & Development
- DIRECTORY
- Healthcare Organisations
- Trade Associations
|
